Fractionated stereotactic radiotherapy with cis-platinum radiosensitization in the treatment of recurrent, progressive, or persistent malignant astrocytoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 20, Issue 3, 1997, Pages 226-229

  Glass, Jon ^a,c,d   Silverman, Craig L ^a   Axelrod, Rita ^a   Corn, Benjamin W ^b   Andrews, David W ^b  

^a TEMPLE UNIVERSITY HEALTH SYSTEM   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antineoplastic agents; Astrocytoma; Brain neoplasm; Cisplatin; Cranial irradiation; Glioma; Radiation sensitizing agents; Radiosurgery; Stereotaxic techniques

Indexed keywords

CISPLATIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TOXICITY; CHILD; CLINICAL ARTICLE; CONFUSION; DEEP VEIN THROMBOSIS; DROWSINESS; FEMALE; HUMAN; LEUKOPENIA; MALE; NAUSEA; OTOTOXICITY; PARANOIA; PERIPHERAL NEUROPATHY; RADIATION NECROSIS; RADIOSENSITIZATION; SEIZURE; THROMBOCYTOPENIA; TUMOR RECURRENCE; UREMIA; VOMITING;

ADOLESCENT; ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; CISPLATIN; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS; RADIOSURGERY; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0031006702     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199706000-00002     Document Type: Article

References (24)

1. Walker MD, Alexander E, Hunt WE, et al. Evaluation of BCNU and/or radiotherapy and nitrosureas in the treatment of anaplastic gliomas. A cooperative clinical tnal. J Neurosurg 1978;49:333-43.
2. Walker MD, Green SP, Byar DP, et al. Randomized comparisons of radiotherapy and nitrosureas for the treatment of malignant glioma after surgery. N Engl J Med 1980;303:1323-9.
3. Hochberg FH, Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology 1980;30:907-11.
4. Salazar OM, Rubin O, McDonald JV, et al. High-dose radiation therapy in the treatment of malignant gliomas: final report. Int J Radiat Oncol Biol Phys 1979;5:1733-40.
5. Sheline GE, Wara WM, Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 1980;6:1215-28.
6. Chang CH, Horton J, Schoenfeld D, et al. Comparison of post-operative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas: a joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer 1979;52:997-1007.
7. Buatti JM, Friedman WA, Bova FJ, Mendenhall WM. LINAC radiosurgery for high-grade glioma: the University of Florida experience. Int J Radiat Oncol Biol Phys 1995;321:205-10.
8. Loeffler JS, Alexander E III, Shea WM, et al. Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol 1992;10:1379-85.
9. Mehta MP, Masciopinto J, Rozental J, et al. Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. Int J Radiat Oncol Biol Phys 1994;30:541-9.
10. Alexander E III, Loeffler JS. Radiosurgery using a modified linear accelerator. Neurosurg Clin North Am 1992;3:167-90.
11. Chamberlain MC, Barba D, Kormanik P, Shea MC. Stereotactic radiosurgery for recurrent gliomas. Cancer 1994;74:1342-7.
12. Souhami L, Olivier A, Podgorsak EB, Villemure J-G, Pla M, Sadikot AF. Fractionated stereotactic radiation therapy for intracranial tumors. Cancer 1991;68:2101-8.
13. Stewart DJ, Leavens M, Maor M, et al. Human central nervous system distribution of cis-diaminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Res 1982;42:2474-9.
14. Chamberlain MC, Barba D, Kormanik P, Berson AM, Saunders WM, Shea MC. Concurrent cisplatin therapy and iodine 125 brachytherapy for recurrent malignant brain tumors. Arch Nrurol 1995;52:162-7.
15. Fontanesi J, Clark WC, Weir A, et al. Interstitial iodine 125 and concomitant cisplatin followed by hyperfractionated external beam irradiation for malignant supratentorial glioma. Preliminary experience at the University of Tennessee, Memphis. Am J Clin Oncol 1993;16:412-7.
16. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990;8:1277-80.
17. Slizofski WJ, Krishna L, Katsetos CD, et al. Thallium imaging for brain tumors with results measured by a semiquantitative index and correlated with histopathology. Cancer 1994;74: 3190-7.
18. Greenberg HS, Chandler WF, Ensminger WD, et al. Radiosensitization with carotid intra-arterial bromodeoxyuridine +/-5-fluorouracil biomodulation for malignant gliomas. Neurology 1994;44:1715-20.
19. Douple EB. Keynote address: Platinum-radiation interactions. NCI Monogr 1988;6:314-9.
20. Douple EB, Richmond RC. Platinum complexes as radiosensitizers of hypoxic mammalian cells. Br J Cancer 1978;37(suppl III):98-102.
21. Coughlin CT, Richmond RC. Biologic and clinical developments of cisplatin combined with radiation: concepts, utility, projections for new trials, and the emergence of carboplatin. Semin Oncol 1989;16:31-43.
22. Kanazawa H, Rapacchietta D, Kallman RF. Schedule-dependent therapeutic gain from the combination of fractionated irradiation and cis-diaminedichloroplatinum (IOI) in C3H/Km mouse model systems. Cancer Res 1988;6:3158-64.
23. Skov K, Macphail S. Interaction of platinum drugs with clinically relevant X-ray doses in mammalian cells: a comparison of cisplatin, carboplatin, iproplatin, and tetraplatin. Int J Radiat Oncol Biol Phys 1991;21:221-5.
24. Decker DA, Kinzie J, Evans R, et al. Pilot study of combination of 5-fluorouracil, cis-diaminedichloroplatinum II and radiation therapy for grade II and IV astrocytomas. Am J Clin Oncol 1987;10:444-7.